Form 8-K - Current report:
SEC Accession No. 0001341004-10-001009
Filing Date
2010-06-09
Accepted
2010-06-09 16:56:49
Documents
6
Period of Report
2010-06-03
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K osi8k.htm 8-K 43398
2 EXHIBIT 3.1: CERTIFICATE OF INCORPORATION ex3-1.htm EX-3.1 14090
3 EXHIBIT 3.2: BYLAWS ex3-2.htm EX-3.2 158311
4 EXHIBIT 99.1: PRESS RELEASE (JUNE 4, 2010) ex99-1.htm EX-99.1 13689
5 EXHIBIT 99.2: PRESS RELEASE (JUNE 9, 2010) ex99-2.htm EX-99.2 14107
6 ex99-11.jpg GRAPHIC 4570
  Complete submission text file 0001341004-10-001009.txt   252228
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 10887684
SIC: 2835 In Vitro & In Vivo Diagnostic Substances